98 related articles for article (PubMed ID: 14601011)
21. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
22. Predicting analysis times in randomized clinical trials.
Bagiella E; Heitjan DF
Stat Med; 2001 Jul; 20(14):2055-63. PubMed ID: 11439420
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
24. Designing complex group sequential survival trials.
Lakatos E
Stat Med; 2002 Jul; 21(14):1969-89. PubMed ID: 12111882
[TBL] [Abstract][Full Text] [Related]
25. Comparing the power of the discontinuation design to that of the classic randomized design on time-to-event endpoints.
Capra WB
Control Clin Trials; 2004 Apr; 25(2):168-77. PubMed ID: 15020035
[TBL] [Abstract][Full Text] [Related]
26. Continuous Bayesian adaptive randomization based on event times with covariates.
Cheung YK; Inoue LY; Wathen JK; Thall PF
Stat Med; 2006 Jan; 25(1):55-70. PubMed ID: 16025549
[TBL] [Abstract][Full Text] [Related]
27. Randomized EVAR trials and advent of level i evidence: a paradigm shift in management of large abdominal aortic aneurysms?
Rutherford RB
Semin Vasc Surg; 2006 Jun; 19(2):69-74. PubMed ID: 16782510
[TBL] [Abstract][Full Text] [Related]
28. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
Kaul S; Diamond GA
Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
[TBL] [Abstract][Full Text] [Related]
29. Tests for treatment group differences in the hazards for survival, before and after the occurrence of an intermediate event.
Bebchuk JD; Betensky RA
Stat Med; 2005 Feb; 24(3):359-78. PubMed ID: 15568187
[TBL] [Abstract][Full Text] [Related]
30. Including multiple imputation in a sensitivity analysis for clinical trials with treatment failures.
Shaffer ML; Chinchilli VM
Contemp Clin Trials; 2007 Feb; 28(2):130-7. PubMed ID: 16877049
[TBL] [Abstract][Full Text] [Related]
31. Cumulative recruitment experience in two large single-center randomized, controlled clinical trials.
Galbreath AD; Smith B; Wood P; Forkner E; Peters JI
Contemp Clin Trials; 2008 May; 29(3):335-42. PubMed ID: 18032118
[TBL] [Abstract][Full Text] [Related]
32. Weibull prediction of event times in clinical trials.
Ying GS; Heitjan DF
Pharm Stat; 2008; 7(2):107-20. PubMed ID: 17377932
[TBL] [Abstract][Full Text] [Related]
33. A general statistical principle for changing a design any time during the course of a trial.
Müller HH; Schäfer H
Stat Med; 2004 Aug; 23(16):2497-508. PubMed ID: 15287080
[TBL] [Abstract][Full Text] [Related]
34. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
[TBL] [Abstract][Full Text] [Related]
35. Interim futility analysis with intermediate endpoints.
Goldman B; LeBlanc M; Crowley J
Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
[TBL] [Abstract][Full Text] [Related]
36. Preventing chronic ectopic bone-related pain and disability after hip replacement surgery with perioperative ibuprofen. A multicenter, randomized, double-blind, placebo-controlled trial (HIPAID).
Fransen M;
Control Clin Trials; 2004 Apr; 25(2):223-33. PubMed ID: 15020038
[TBL] [Abstract][Full Text] [Related]
37. Comparing outcomes on peritoneal and hemodialysis: a case study in the interpretation of observational studies.
Davies SJ
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):24-30. PubMed ID: 17237887
[No Abstract] [Full Text] [Related]
38. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Hermosillo AJ; Spinler SA
Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
[TBL] [Abstract][Full Text] [Related]
39. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
[TBL] [Abstract][Full Text] [Related]
40. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
